• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外使用鼠源抗原特异性 CD4 和 CD8 T 细胞评估人骨髓间充质干细胞的免疫抑制活性。

Assessment of immunosuppressive activity of human mesenchymal stem cells using murine antigen specific CD4 and CD8 T cells in vitro.

出版信息

Stem Cell Res Ther. 2013 Oct 22;4(5):128. doi: 10.1186/scrt339.

DOI:10.1186/scrt339
PMID:24406271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3854780/
Abstract

INTRODUCTION

Mesenchymal stem cells (MSCs) have immunosuppressive activity. They do not induce allospecific T cell responses, making them promising tools for reducing the severity of graft versus host disease (GVHD) as well as treating various immune diseases. Currently, there is a need in the MSC field to develop a robust in vitro bioassay which can characterize the immunosuppressive function of MSCs.

METHODS

Murine clonal CD4 and CD8 T cells were stimulated with cognate peptide antigen and antigen presenting cells (APCs) in the absence or presence of human MSCs, different aspects of T cell activation were monitored and analyzed using flow cytometry, real time RT-PCR and cytokine measurement.

RESULTS

Human MSCs (hMSCs) can alter multiple aspects of murine T cell activation induced by stimulation with specific antigen, including: reduced proliferation, inhibited or stimulated cell surface marker expression (CD25, CD69, CD44 and CD62L), inhibited mRNA expression of transcription factors (T-bet and GATA-3) and decreased cytokine expression (interferon-gamma, interleukin-10). Disappearance of activation-induced cluster formation and decreased apoptosis of CD8 T cells were also observed. Moreover, the effects are specific to MSCs; incubating the T cells with non-MSC control cell lines had no effect on T cell proliferation and activation.

CONCLUSIONS

Clonal murine T cells can be used to measure, characterize, and quantify the in vitro immunosuppressive activity of human MSCs, representing a promising approach to improve bioassays for immunosuppression.

摘要

简介

间充质干细胞(MSCs)具有免疫抑制活性。它们不会诱导同种异体 T 细胞反应,因此有望降低移植物抗宿主病(GVHD)的严重程度,并治疗各种免疫疾病。目前,MSC 领域需要开发一种强大的体外生物测定法,以表征 MSCs 的免疫抑制功能。

方法

在缺乏或存在人 MSCs 的情况下,用同源肽抗原和抗原呈递细胞(APCs)刺激小鼠克隆 CD4 和 CD8 T 细胞,使用流式细胞术、实时 RT-PCR 和细胞因子测量监测和分析 T 细胞激活的各个方面。

结果

人 MSCs(hMSCs)可以改变由特异性抗原刺激引起的小鼠 T 细胞激活的多个方面,包括:增殖减少、细胞表面标记物(CD25、CD69、CD44 和 CD62L)的表达受抑制或受刺激、转录因子(T-bet 和 GATA-3)的 mRNA 表达受抑制以及细胞因子表达(干扰素-γ、白细胞介素-10)降低。还观察到激活诱导的簇形成消失和 CD8 T 细胞凋亡减少。此外,这些效应是特异于 MSCs 的;将 T 细胞与非 MSC 对照细胞系孵育不会影响 T 细胞增殖和激活。

结论

克隆小鼠 T 细胞可用于测量、表征和量化人 MSCs 的体外免疫抑制活性,这代表了改善免疫抑制生物测定法的有前途的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/e73a5d9ad884/scrt339-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/5276f90611bc/scrt339-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/3b9422f1e57f/scrt339-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/4d14b2c34b44/scrt339-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/94240e8f0f56/scrt339-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/57a1916d1726/scrt339-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/90c1e78eb0e0/scrt339-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/25a336a08668/scrt339-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/94d01e8448d3/scrt339-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/65ea3494afbe/scrt339-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/e73a5d9ad884/scrt339-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/5276f90611bc/scrt339-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/3b9422f1e57f/scrt339-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/4d14b2c34b44/scrt339-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/94240e8f0f56/scrt339-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/57a1916d1726/scrt339-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/90c1e78eb0e0/scrt339-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/25a336a08668/scrt339-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/94d01e8448d3/scrt339-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/65ea3494afbe/scrt339-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b47a/3854780/e73a5d9ad884/scrt339-10.jpg

相似文献

1
Assessment of immunosuppressive activity of human mesenchymal stem cells using murine antigen specific CD4 and CD8 T cells in vitro.体外使用鼠源抗原特异性 CD4 和 CD8 T 细胞评估人骨髓间充质干细胞的免疫抑制活性。
Stem Cell Res Ther. 2013 Oct 22;4(5):128. doi: 10.1186/scrt339.
2
Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.间充质干细胞在Th1和Th17细胞分化过程中产生CD4+CD25+Foxp3+调节性T细胞群体。
Stem Cell Res Ther. 2013 Jun 4;4(3):65. doi: 10.1186/scrt216.
3
Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.人骨髓间充质基质细胞对外周血初始、记忆和效应T细胞产生细胞因子的影响。
Stem Cell Res Ther. 2015 Jan 5;6(1):3. doi: 10.1186/scrt537.
4
The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.人骨髓间充质干细胞的免疫抑制作用针对T细胞增殖而非其效应功能。
Cell Immunol. 2008 Feb;251(2):131-6. doi: 10.1016/j.cellimm.2008.04.009. Epub 2008 May 27.
5
Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells.骨髓间充质干细胞诱导活化T细胞发生分裂阻滞失能。
Blood. 2005 Apr 1;105(7):2821-7. doi: 10.1182/blood-2004-09-3696. Epub 2004 Dec 9.
6
Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients.人骨髓间充质基质/干细胞对类风湿关节炎患者外周血 T 细胞的免疫调节作用。
J Tissue Eng Regen Med. 2020 Jan;14(1):16-28. doi: 10.1002/term.2958. Epub 2019 Nov 11.
7
Morphological profiling using machine learning reveals emergent subpopulations of interferon-γ-stimulated mesenchymal stromal cells that predict immunosuppression.使用机器学习进行形态分析揭示了干扰素-γ刺激的间充质基质细胞的新兴亚群,这些亚群可预测免疫抑制。
Cytotherapy. 2019 Jan;21(1):17-31. doi: 10.1016/j.jcyt.2018.10.008. Epub 2018 Nov 28.
8
Human fetal liver MSCs are more effective than adult bone marrow MSCs for their immunosuppressive, immunomodulatory, and Foxp3 T reg induction capacity.人胎肝间充质干细胞比成人骨髓间充质干细胞在免疫抑制、免疫调节和 Foxp3 T 调节诱导能力方面更有效。
Stem Cell Res Ther. 2021 Feb 17;12(1):138. doi: 10.1186/s13287-021-02176-1.
9
Differential kinetics of antigen dependency of CD4+ and CD8+ T cells.CD4+和 CD8+T 细胞对抗原依赖性的差异动力学。
J Immunol. 2014 Apr 15;192(8):3507-17. doi: 10.4049/jimmunol.1302725. Epub 2014 Mar 17.
10
Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.间充质干细胞对克罗恩病黏膜T细胞的体外免疫抑制作用很大程度上依赖于吲哚胺2,3-双加氧酶活性和细胞间接触。
Stem Cell Res Ther. 2015 Jul 24;6(1):137. doi: 10.1186/s13287-015-0122-1.

引用本文的文献

1
Therapeutic Effects of Mesenchymal/Stromal Stem Cells and Their Derived Extracellular Vesicles in Rheumatoid Arthritis.间充质/基质干细胞及其衍生的细胞外囊泡在类风湿关节炎中的治疗作用。
Stem Cells Transl Med. 2023 Dec 18;12(12):849-862. doi: 10.1093/stcltm/szad065.
2
Mesenchymal stem cells: a promising way in therapies of graft-versus-host disease.间充质干细胞:治疗移植物抗宿主病的一种有前景的方法。
Cancer Cell Int. 2020 Apr 7;20:114. doi: 10.1186/s12935-020-01193-z. eCollection 2020.
3
The Human IL-23 Decoy Receptor Inhibits T-Cells Producing IL-17 by Genetically Engineered Mesenchymal Stem Cells.

本文引用的文献

1
Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal.多能间充质基质细胞的免疫特性——国际细胞治疗学会(ISCT)工作提案。
Cytotherapy. 2013 Sep;15(9):1054-61. doi: 10.1016/j.jcyt.2013.02.010. Epub 2013 Apr 17.
2
Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation.间充质干细胞是否能跨越物种屏障发挥作用?与异种移植的相关性。
Xenotransplantation. 2012 Sep-Oct;19(5):273-85. doi: 10.1111/xen.12000.
3
Quantitative approaches to detect donor and passage differences in adipogenic potential and clonogenicity in human bone marrow-derived mesenchymal stem cells.
人白细胞介素-23诱饵受体通过基因工程化间充质干细胞抑制产生白细胞介素-17的T细胞。
Int J Cell Biol. 2018 Dec 19;2018:8213912. doi: 10.1155/2018/8213912. eCollection 2018.
4
Advance in Targeted Immunotherapy for Graft-Versus-Host Disease.靶向免疫治疗移植物抗宿主病的进展。
Front Immunol. 2018 May 16;9:1087. doi: 10.3389/fimmu.2018.01087. eCollection 2018.
5
MicroRNA expression in bone marrow-derived human multipotent Stromal cells.骨髓来源的人多能基质细胞中的微小RNA表达
BMC Genomics. 2017 Aug 11;18(1):605. doi: 10.1186/s12864-017-3997-7.
6
Cellular Therapies for Treatment of Radiation Injury: Report from a NIH/NIAID and IRSN Workshop.用于治疗辐射损伤的细胞疗法:美国国立卫生研究院/美国国立过敏与传染病研究所及法国辐射防护与核安全研究所研讨会报告
Radiat Res. 2017 Aug;188(2):e54-e75. doi: 10.1667/RR14810.1. Epub 2017 Jun 12.
7
Chromosomal stability of mesenchymal stromal cells during in vitro culture.间充质基质细胞在体外培养过程中的染色体稳定性
Cytotherapy. 2016 Mar;18(3):336-43. doi: 10.1016/j.jcyt.2015.11.017. Epub 2016 Jan 15.
8
Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34(pos) Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction.诱导多能干细胞来源的间充质干细胞支持 CD34(+)造血干细胞的增殖并抑制炎症反应。
Stem Cells Int. 2015;2015:843058. doi: 10.1155/2015/843058. Epub 2015 Jun 22.
9
Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models.人骨髓间充质基质细胞在BALB/c宿主移植物抗宿主病小鼠模型中的免疫抑制机制
Exp Hematol Oncol. 2015 Apr 30;4:13. doi: 10.1186/s40164-015-0007-0. eCollection 2015.
10
Wharton's Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease.源自华通氏胶的间充质基质细胞作为治疗移植物抗宿主病的一种有前景的细胞治疗策略
Pharmaceuticals (Basel). 2015 Apr 16;8(2):196-220. doi: 10.3390/ph8020196.
定量方法检测人骨髓间充质干细胞成脂潜能和克隆形成能力中的供体和传代差异。
Tissue Eng Part C Methods. 2012 Nov;18(11):877-89. doi: 10.1089/ten.TEC.2011.0736. Epub 2012 Jun 25.
4
Immunosuppressive properties of mesenchymal stem cells.间充质干细胞的免疫抑制特性。
Stem Cell Rev Rep. 2012 Jun;8(2):375-92. doi: 10.1007/s12015-011-9312-0.
5
Mesenchymal stem cells: mechanisms of inflammation.间充质干细胞:炎症机制。
Annu Rev Pathol. 2011;6:457-78. doi: 10.1146/annurev-pathol-011110-130230.
6
Human foreskin fibroblasts exert immunomodulatory properties by a different mechanism to bone marrow stromal/stem cells.人包皮成纤维细胞通过与骨髓基质/干细胞不同的机制发挥免疫调节作用。
Stem Cells Dev. 2011 Apr;20(4):647-59. doi: 10.1089/scd.2010.0246. Epub 2010 Oct 12.
7
Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates.间充质干细胞增强非人类灵长类动物同种异体胰岛移植物的植入。
Diabetes. 2010 Oct;59(10):2558-68. doi: 10.2337/db10-0136. Epub 2010 Jul 9.
8
Therapeutic potential of bone-marrow-derived mesenchymal stem cells differentiated with growth-factor-free coculture method in liver-injured rats.无生长因子共培养法诱导骨髓间充质干细胞向肝系细胞分化的治疗潜能在肝损伤大鼠中的研究。
Tissue Eng Part A. 2010 Aug;16(8):2649-59. doi: 10.1089/ten.TEA.2009.0814.
9
Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.间充质干细胞共移植可能在非清髓性预处理 HLA mismatched 异基因移植后防止移植物抗宿主病 (GVHD) 导致的死亡,而不会消除移植物抗肿瘤效应。
Biol Blood Marrow Transplant. 2010 Jun;16(6):838-47. doi: 10.1016/j.bbmt.2010.01.011. Epub 2010 Jan 28.
10
Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders.间充质基质细胞的免疫调节特性及其对免疫介导性疾病的治疗后果。
Stem Cells Dev. 2010 May;19(5):607-14. doi: 10.1089/scd.2009.0345.